Abstract
Serotonin (5-HT) is an essential neurotransmitter for cognitive functions and formation of new memories. A deficit in 5-HT dependent neuronal activity is somewhat specific for Alzheimer’s disease. Metal-mediated oxidative degradation of neurotransmitters by Aβ bound to metals has been investigated. Heme-bound Aβ is found to catalyze the oxidative degradation of 5-HT leading to the formation of neurotoxic products dihydroxybitryptamine and tyrptamine-4,5-dione. The catalytic degradation of 5-HT is of first order with respect to both heme–Aβ and H2O2, and the maximum rate of 5-HT oxidation is obtained at physiological pH (pH 7–7.5). pH perturbation of the binding affinity of heme–Aβ complex for 5-HT indicates that the binding of the substrate (5-HT) is not the rate-determining step. Arg5 acts as a second-sphere residue facilitating the O–O bond cleavage, the mutation of which leads to a decrease in the rate of 5-HT oxidation. The pull effect of the Arg5 residue tends to facilitate the generation of the active oxidant, Compound I, below neutral pH, while the ionization of the phenol group of the substrate facilitates the generation of the active substrate above neutral pH. A combination of these two opposing effects results in the highest activity at physiological pH. Apart from the Arg5 residue, the Tyr10 residue is found to play a vital role in the 5-HT oxidation by heme–Aβ complexes.
Similar content being viewed by others
References
Rauk A (2009) Chem Soc Rev 38:2698–2715
Rodríguez JJ, Noristani HN, Verkhratsky A (2012) Progress Neurobiol 99:15–41
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Proc Natl Acad Sci USA 82:4245–4249
Glenner GG, Wong CW (1984) Biochem Biophys Res Commun 120:885–890
Selkoe DJ (2000) Ann N Y Acad Sci 924:17–25
Parker WD, Ba JP, Filley CM, Kleinschmidt-DeMasters BK (1994) Neurology 44:1090–1096
Mutisya EM, Bowling AC, Beal MF (1994) J Neurochem 63:2179–2184
Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992) J Neurosci Res 31:327–335
Smith MA, Nunomura A, Zhu X, Takeda A, Perry G (2000) Antioxid Redox Signal 2:413–420
Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q (2012) Progress Neurobiol 97:1–13
Atamna H, Boyle K (2006) Proc Natl Acad Sci USA 103:3381–3386
Hardy J, Selkoe DJ (2002) Science 297:353–356
Bush AI (2003) Trends Neurosci 26:207–214
LeVine SM (1997) Brain Res 760:298–303
Atamna H, Frey WH (2004) Proc Natl Acad Sci USA 101:11153–11158
Atamna H, Liu J, Ames BN (2001) J Biol Chem 276:48410–48416
Atamna H, Killilea DW, Killilea AN, Ames BN (2002) Proc Natl Acad Sci USA 99:14807–14812
Pramanik D, Dey SG (2011) J Am Soc Chem 133:81–87
Pramanik D, Ghosh C, Mukherjee S, Dey SG (2013) Coord Chem Rev 257:81–92
Atamna H, Frey Ii WH, Ko N (2009) Arch Biochem Biophys 487:59–65
Bao Q, Luo Y, Li W, Sun X, Zhu C, Li P, Huang Z-X, Tan X (2011) J Biol Inorg Chem 16:809–816
Arnsten AFT, Li B-M (2005) Biol Psychiatry 57:1377–1384
Larson EB, Kukull WA, Katzman RL (1992) Annu Rev Public Health 13:431–449
Friedman JI, Adler DN, Davis KL (1999) Biol Psychiatry 46:1243–1252
Li JIE, Zhu MIN, Manning-Bog AB, Di Monte DA, Fink AL (2004) FASEB J 18:962–964
da Silva GFZ, Tay WM, Ming L-J (2005) J Biol Chem 280:16601–16609
da Silva GFZ, Ming L-J (2005) Angew Chem 117:5637–5640
da Silva GFZ, Ming L-J (2007) Angew Chem 119:3401–3405
Ciregna D, Monzani E, Thiabaud G, Pizzocaro S, Casella L (2013) Chem Commun 49:4027–4029
Thiabaud G, Pizzocaro S, Garcia-Serres R, Latour J-M, Monzani E, Casella L (2013) Angew Chem Int Ed 52:8041–8044
Pramanik D, Sengupta K, Mukherjee S, Dey SG, Dey A (2012) J Am Soc Chem 134:12180–12189
Pramanik D, Ghosh C, Dey SG (2011) J Am Soc Chem 133:15545–15552
Halliday GM, McCann HL, Pamphlett R, Brooks WS, Creasey H, McCusker E, Cotton RGH, Broe GA, Harper CG (1992) Acta Neuropathol 84:638–650
Lyness SA, Zarow C, Chui HC (2003) Neurobiol Aging 24:1–23
Chen CPLH, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM (2000) Neuropathol Appl Neurobiol 26:347–355
Bowen DM, Procter AW, Mann DMA, Snowden JS, Esiri MM, Neary D, Francis PT (2008) Psychopharmacology 196:603–610
Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CPLH, Francis PT, Lasheras B, Ramirez MJ (2005) Neuropsychologia 43:442–449
Lai MKP, Tsang SWY, Francis PT, Keene J, Hope T, Esiri MM, Spence I, Chen CPLH (2002) Neuroreport 13:1175–1178
Dunford HB, Hsuanyu Y (1999) Biochem Cell Biol 77:449–457
Kishi T, Tanaka M, Tanaka J (1977) Bull Chem Soc Jpn 50:1267–1271
Yi L, Ragsdale SW (2007) J Biol Chem 282:21056–21067
Ximenes VF, Maghzal GJ, Turner R, Kato Y, Winterbourn CC, Kettle AJ (2010) Biochem J 425:285–293
Neumann B, Yarman A, Wollenberger U, Scheller F (2014) Anal Bioanal Chem 406:3359–3364
Heinecke JW, Li W, Daehnke HL, Goldstein JA (1993) J Biol Chem 268:4069–4077
Waley SG (1975) Biochem J 149:547
Ghosh C, Pramanik D, Mukherjee S, Dey A, Dey SG (2013) Inorg Chem 52:362–368
Winterbourn CC, Kettle AJ (2003) Biochem Biophys Res Commun 305:729–736
Fang X, Jin F, Jin H, von Sonntag C (1998) J Chem Soc Perkin Trans 2:259–264
Subrahmanyam VV, Kolachana P, Smith MT (1991) Arch Biochem Biophys 286:76–84
Dolphin D, Forman A, Borg DC, Fajer J, Felton RH (1971) Proc Natl Acad Sci USA 68:614–618
La Mar GN, de Ropp JS, Smith KM, Langry KC (1981) J Biol Chem 256:237–243
Kaneko Y, Tamura M, Yamazaki I (1980) Biochemistry 19:5795–5799
George P (1953) Biochem J 54:267–276
Smulevich G, Feis A, Howes B (2005) Acc Chem Res 38:433–440
Adak S, Mazumder A, Banerjee RK (1996) Biochem J 314:985–991
Crino PB, Vogt BA, Chen J-C, Volicer L (1989) Brain Res 504:247–257
Wong K-S, Goyal RN, Wrona MZ, Blank CL, Dryhurst G (1993) Biochem Pharmacol 46:1637–1652
Jiang XR, Wrona MZ, Alguindigue SS, Dryhurst G (2004) Chem Res Toxicol 17:357–369
Jiang XR, Dryhurst G (2002) Chem Res Toxicol 15:1242–1247
Wrona MZ, Dryhurst G (2001) Chem Res Toxicol 14:1184–1192
Burke WJ, Chung HD, Huang JS, Huang SS, Haring JH, Strong R, Marchshall GL, Joh TH (1988) Ann Neurol 24:532–536
Marcyniuk B, Mann DM, Yates PO (1986) J Neurol Sci 76:335–345
Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R, Masters CL, Tanzi RE, Inestrosa NC, Bush AI (2002) J Biol Chem 277:40302–40308
Acknowledgments
We thank SERC Fast Track Scheme SR/FT/CS-34/2010, Department of Science and Technology, Government of India and IACS for funding this research. S. M. is thankful to the Council of Scientific and Industrial Research, India, for a Junior Research Fellowship. M. S. is thankful to IACS-integrated Ph.D. programme for Junior Research Fellowship. We thank Professor T. K. Mandal of Polymer Science Unit, IACS, for allowing us to use his HPLC machine (Waters 1525 Separation Module) and Dr. Abhishek Dey for his helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
775_2014_1193_MOESM1_ESM.pdf
Area under the curve for 5-HT and residual 5-HT after oxidation obtained from HPLC data, separation of the 5-HT and its products by RP-HPLC after its incubation with excess heme–Aβ, Eadie-Hofstee plots of 5-HT oxidation by heme–Aβ(1–16), saturation plot of the initial rate of oxidation of 5-HT (ΔA 317nm/s) by heme- heme–Aβ(1–16) against various 5-HT concentration at different pH, absorption spectra of 5-HT titration to heme–Aβ(1–16) and K d values at different pH, absorption spectra of 5-HT titration heme-bound Tyr10Phe mutant of Aβ(1–16) at different pH values, 5HT titration with free heme are available online as ESI. (PDF 3121 kb)
Rights and permissions
About this article
Cite this article
Mukherjee, S., Seal, M. & Dey, S.G. Kinetics of serotonin oxidation by heme–Aβ relevant to Alzheimer’s disease. J Biol Inorg Chem 19, 1355–1365 (2014). https://doi.org/10.1007/s00775-014-1193-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-014-1193-7